EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia

Woo-Sung Kim, Da-Woon Heo iD, Jie Shen, Uyanga Tsogt, Soyolsaikhan Odkhuu, Sung-Wan Kim, Heung-Il Suk, Byung-Joo Ham, Fatima Zahra Rami, Chae Yeong Kang, Jing Sui, Young-Chul Chung iD

International Journal of Neuropsychopharmacology · 22.03.2023 · 26 (3) · 207-216

DOI: 10.1093/ijnp/pyac080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 21.12.2022. Verfasst von Woo-Sung Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Jeonbuk National University, Medical School, Jeonju, Korea. Hauptthemen laut MEDLINE: Schizophrenia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain age is a popular brain-based biomarker that offers a powerful strategy for using neuroscience in clinical practice. We investigated the brain-predicted age difference (PAD) in patients with schizophrenia (SCZ), first-episode schizophrenia spectrum disorders (FE-SSDs), and treatment-resistant schizophrenia (TRS) using structural magnetic resonance imaging data. The association between brain-PAD and clinical parameters was also assessed.

Methods

We developed brain age prediction models for the association between 77 average structural brain measures and age in a training sample of controls (HCs) using ridge regression, support vector regression, and relevance vector regression. The trained models in the controls were applied to the test samples of the controls and 3 patient groups to obtain brain-based age estimates. The correlations were tested between the brain PAD and clinical measures in the patient groups.

Results

Model performance indicated that, regardless of the type of regression metric, the best model was support vector regression and the worst model was relevance vector regression for the training HCs. Accelerated brain aging was identified in patients with SCZ, FE-SSDs, and TRS compared with the HCs. A significant difference in brain PAD was observed between FE-SSDs and TRS using the ridge regression algorithm. Symptom severity, the Social and Occupational Functioning Assessment Scale, chlorpromazine equivalents, and cognitive function were correlated with the brain PAD in the patient groups.

Conclusions

These findings suggest additional progressive neuronal changes in the brain after SCZ onset. Therefore, pharmacological or psychosocial interventions targeting brain health should be developed and provided during the early course of SCZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaHumansSchizophrenia, Treatment-ResistantBrainAgingMagnetic Resonance Imaging

Stichwörter der Autor:innen

Brain agesMRIschizophreniasupport vector regression

Autor:innen und Institutionen

  • Department of Psychiatry, Jeonbuk National University, Medical School, Jeonju, Korea.
  • Department of Brain and Cognitive Engineering, Korea University, Seoul, Korea.
  • Department of Artificial Intelligence, Korea University, Seoul, Korea.
  • Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.
  • Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.
  • Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

ORCID-Profile: Da-Woon Heo, Young-Chul Chung

Förderung

  • Ministry of Health and Welfare, Republic of Korea

Zitieren

APA

Kim, W. S., Heo, D. W., Shen, J., Tsogt, U., Odkhuu, S., Kim, S. W., Suk, H. I., Ham, B. J., Rami, F. Z., Kang, C. Y., Sui, J., & Chung, Y. C. (2023). Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia. International Journal of Neuropsychopharmacology, 26(3), 207-216. https://doi.org/10.1093/ijnp/pyac080

Vancouver

Kim WS, Heo DW, Shen J, Tsogt U, Odkhuu S, Kim SW, et al. Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia. International Journal of Neuropsychopharmacology. 2023;26(3):207-216. doi:10.1093/ijnp/pyac080

BibTeX
@article{Kim2023,
  author = {Kim, Woo-Sung and Heo, Da-Woon and Shen, Jie and Tsogt, Uyanga and Odkhuu, Soyolsaikhan and Kim, Sung-Wan and Suk, Heung-Il and Ham, Byung-Joo and Rami, Fatima Zahra and Kang, Chae Yeong and Sui, Jing and Chung, Young-Chul},
  title = {Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2023},
  volume = {26},
  number = {3},
  pages = {207--216},
  doi = {10.1093/ijnp/pyac080}
}
Kostenlos starten →